“Anti-TNF Treatment In Refractory Sarcoidosis; Therapeutic Impacts Of Adalimumab And Infliximab”. The Review of Diabetic Studies , Apr. 2025, pp. 120-3, https://doi.org/10.70082/crmrkr78.